NimbleGen HD2 Arrays
Roche NimbleGen introduces NimbleGen HD2 microarrays for Comparative Genomic Hybridization (CGH) and ChIP-chip analysis of eukaryotic organisms. With 2.1 million probes, NimbleGen HD2 arrays offer the opportunity to fully interrogate copy number variation, transcription factor binding, and chromatin structure.
advantages:
More Probes Enable Increased Resolution and Cost-Effective Analysis
With 2.1 million probes, NimbleGen HD2 arrays offer the highest density microarray platform currently available for CGH and ChIP-chip analysis. NimbleGen HD2 arrays enable genome-wide detection of copy number variation down to ~5 kb resolution (human) and transcription factor binding at 100bp resolution. Fewer HD2 arrays and less total sample are required to perform genome-wide ChIP-chip studies, which leads to a significant reduction in cost to perform such analyses.
Long Oligonucleotide Probes Enhance the Accuracy of Your Analysis
NimbleGen HD2 arrays utilize long oligo probes, which have been shown to provide increased sensitivity, specificity, and reproducibility. Depending on the specific array design, HD2 arrays are synthesized with oligos between 50 and 75 bases in length.
Only the Most Current Genomes
The inherent flexibility of the Roche NimbleGen technology enables the rapid creation of array designs using the most current genomic sequence from any eukaryotic genome. NimbleGen HD2 arrays will deliver the highest resolution and highest quality CGH and ChIP-chip data on the latest genomic build.
